Imatinib Recruiting Phase 2 Trials for Chronic Myeloid Leukemia (CML) / Philadelphia Chromosome Positive CML Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03241199The Efficacy and Safety of Induction-Maintenance Protocol for Patients With Chronic Myelogenous Leukaemia